USA Laser Biotech Inc. has received FDA 510(k) clearance for the Lumix laser series, combining and synchro nizing high-power super-pulsed and co ntinuous wave capabilities.

The Lumix 3 and Lumix 4 lasers provide pulse rates of up to 100,000 Hz. Higher pulse rates offer more treatment options such as the photomechanical effect for care of chro nic conditions. The lasers also introduce the integration of super-pulsed and the 1064-nm wavelength with up to 30 W to the U.S. In Europe, the 1064-nm wavelength is recognized as a thermally safer co ntinuous wave therapy than other commo nly used wavelengths.

The lasers also deliver up to 45 W of peak penetration power, using three or four synchro nized wavelengths. The Lumix 3 and Lumix 4 Series of 45-W desktop models are available with wavelength options to suit chiropractic, dental, general practice, physical therapy, podiatric, sports medicine and veterinary applications.